Relmada (RLMD) - Kapitalizatsiyaning foydaga nisbati
Relmada Therapeutics (RLMD) psixiatrlar tomonidan tan olinishiga va depressiyani davolash bo'yicha ishlanmalariga bo'lgan ishonchga tayanadi. Kompaniya markaziy nerv tizimi agentlarini yaratadi, bunda joriy sinov xarajatlari patentlashdan keyin yuqori daromadlar bilan almashtiriladi. -7.70 metriki bilan taqdim etilgan ushbu narxlar grafigi quyida mavjud. Biroq, sanksiyalar va harbiy mojarolar ko'ngillilarni xalqaro miqyosda qidirishni murakkablashtirib, yangi dori vositalarining sertifikatlashtirilishini sekinlashtirmoqda.
Relmada (RLMD) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya kursi va ekspertlarning narx prognozi:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Umumiy qarzning kapitalga nisbati Relmada Therapeutics|RLMD - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi Relmada Corp|RLMD - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar Relmada Therapeutics, Inc.|RLMD - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli kredit va qarzlari Relmada Therapeutics|Oraliq likvidlik koeffitsiyenti relmada.com
- foyda va bozor koeffitsiyentlari statistikasi:
RLMD - Sof foyda|Kutilayotgan sof daromad Relmada Therapeutics|RLMD - P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Relmada Therapeutics Inc|RLMD - Narxning foydaga va o‘sish sur’atiga nisbati|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati Relmada Therapeutics, Inc.|RLMD - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Relmada Therapeutics|RLMD - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik dinamikasi relmada.com|RLMD - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi Relmada Therapeutics
Kompaniyaning jamlanma tahlili:RLMD, relmada.com
Uzoq muddatli portfelni shakllantirishda, aktivlarni saralash investitsiya qitib chiqish muddatini bozor qiymatining sof foydaga nisbati orqali baholashdan boshlanadi. Kapital xarajatlarini minimallashtirish uchun ishlab chiqarishni autsorsing qilishdan foydalanadigan Relmada Therapeutics (RLMD) uchun ushbu ko'rsatkich uning ilmiy modelining samaradorligini aks ettiradi va GURU.Markets platformasida kompaniyaning fundamental P/E ko'rsatkichi orqali biznes qiymati dinamikasini batafsil kuzatish imkonini beradi.
Raqobatdosh kompaniyalar
BIIB: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori NBIX|RGC - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Axsome Therapeutics Inc AXSM|ACADIA Corp - Narxning foydaga nisbati|XENE - Narxning foydaga nisbati|vikingtherapeutics.com (VKTX) - Narx-foyda koeffitsiyenti|SUPN: P/E multiplikatori|Catalyst Pharma (CPRX) - P/E multiplikatori|DNLI (Denali Therapeutics Inc) - P/E multiplikatori|Narx-foyda multiplikatori HRMY (Harmony Corp)|P/E multiplikatori BHVN|P/E multiplikatori amylyx.com (AMLX)|Trevi Therapeutics, Inc. - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati PRAX|AVXL: Narx-foyda koeffitsiyenti|CeriBell EEG - Bozor narxining sof foydaga nisbati|PRTA: P/E multiplikatori|Alector - Kompaniya qiymatining sof foydaga nisbati|ANNX (Annexon) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Omeros Corp. OMER|Narxning foydaga nisbati Neurogene Corp (NGNE)|ACIU (AC Immune Inc) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori VYGR (Voyager Therapeutics)|P/E multiplikatori neumoratx.com NMRA|SCLX - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati TVGN|ACOG: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Cognition Therapeutics Inc. (CGTX)|Narx-foyda koeffitsiyenti IKT|P/E multiplikatori cassavasciences.com|Narx-foyda koeffitsiyenti ASRT (Assertio Holdings, Inc.)|Bozor narxining sof foydaga nisbati COYA|P/E multiplikatori VTGN (Vistagen)|Biznesning o‘zini qoplash muddati Ovid Therapeutics Inc (OVID)|Acumen Pharmaceuticals - P/E multiplikatori|cervomed.com (CRVO) - Narx-foyda koeffitsiyenti|alteritytherapeutics.com (ATHE) - Narxning foydaga nisbati|CLNN - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati PepGen Inc|JUNS: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Annovis Bio, Inc. (ANVS)|Narxning foydaga nisbati GRCE (gracetx.com)|Narxning foydaga nisbati Firefly Neuroscience AIFF|KLTO - Narx-foyda koeffitsiyenti|NeuroSense Therapeutics, Ltd. - P/E multiplikatori|RVPH (Reviva Pharmaceuticals, Inc.) - Narx-foyda multiplikatori|metaviatx.com (MTVA) - Narxning foydaga nisbati|Narx-foyda multiplikatori NRXS|HSDT (Helius Medical Technologies, Inc.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Passage Bio Corp PASG|Narx-foyda koeffitsiyenti NEUP (Neuphoria Therapeutics Inc.)|P/E multiplikatori Minerva (NERV)|Narxning foydaga nisbati Athira Pharma, Inc. ATHA|Kompaniya qiymatining sof foydaga nisbati ADXN|ALZN - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Cyclerion Therapeutics|protagenic.com (PTIX) - Narxning foydaga nisbati|Pasithea Therapeutics Corp. - Kompaniya qiymatining sof foydaga nisbati|CRGT (Cortigent Inc) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati avenuetx.com ATXI|Narxning foydaga nisbati BrainStorm Cell Therapeutics (BCLI)|Narxning foydaga nisbati CARA (Cara Therapeutics Inc.)|Narxning foydaga nisbati Chromocell Therapeutics Corporation CHRO|ELYM - Narx-foyda koeffitsiyenti|Intra-Cellular - P/E multiplikatori|LBPH - P/E multiplikatori|MRNS: P/E multiplikatori|Narx-foyda multiplikatori NKGN|NRBO (NeuroBo) - P/E multiplikatori|P/E multiplikatori Sage Therapeutics Inc|Narx-foyda koeffitsiyenti SNPX (Synaptogenix, Inc.)|TRVN (trevena.com) - Kompaniya qiymatining sof foydaga nisbati|Vigil Neuroscience, Inc. - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati WENA (anewmeds.com)|Cerevel - P/E multiplikatori
